Cyclopharm Limited (ASX: CYC) is pleased to announce that it has gained regulatory approval to sell its Technegas products in Russia; furthermore, the Company has secured its first order for a
Technegas Generator and associated Patient Administration Sets.
Russia represents the 60th country globally where Technegas is now available. The order highlights Technegas’ ongoing organic growth potential and marks a significant increase to the global
Technegas footprint.
For more information, download the attached PDF.
Download this document
